Irving-based Caris Life Sciences will be adding a 26th cancer center to its Precision Oncology Alliance when the Sylvester Comprehensive Cancer Center at the Miami Miller School of Medicine joins the group. The alliance is a network of cancer centers that work together to develop standards of care and best practices to improve cancer treatment.
Caris Life Sciences is a biotechnology company that addresses cancer and other diseases through several platforms that inform drug development and other treatment. The Precision Oncology Alliance helps lead the development of precision cancer care, and the Miami center will add to the alliance’s collection of molecular data and and patient outcome information.
“Sylvester Comprehensive Cancer Center is well recognized as a leader in cancer care, and we are delighted to add its expertise to the growing Precision Oncology Alliance,” said Brian J. Brille, Vice Chairman of Caris Life Sciences via release.
“We look forward to working with Caris and the other members of the Precision Oncology Alliance to collectively advance and provide greater patient access to precision cancer care, and continue to make significant gains along every measure of clinical and operational excellence,” said Stephen Nimer, M.D., Director, Sylvester Comprehensive Cancer Center via release.
Michael Korn, M.D., Chief Medical Officer at Caris Life Sciences, added via release, “The Sylvester Comprehensive Cancer Center is dedicated to applying the latest in cancer research to patient care, rigorously evaluating effectiveness of new treatments, and offering treatment approaches rooted in new clinical trial opportunities. The Precision Oncology Alliance will benefit from the institution’s engagement and focus on diversity.”
